This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Audiocure Pharma Gmbh. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Tomasz Zygmunt
Introduction
Tomasz Zygmunt is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable polymorphic forms of compounds. His work is aimed at addressing critical health issues, including hearing damage and vestibular disorders.
Latest Patents
Tomasz Zygmunt holds a patent for a stable polymorphic form of 6-fluoro-9-methyl-9H-β-carboline. This invention includes a method for preparing the crystalline polymorphic form and a pharmaceutical composition that incorporates it. The stable crystalline polymorphic form is intended for use in the treatment and prophylaxis of hearing damage, vertigo, or vestibular disorders.
Career Highlights
Zygmunt is associated with Audiocure Pharma GmbH, where he applies his expertise in pharmaceutical innovations. His work has led to advancements in the treatment of auditory and vestibular conditions, showcasing his commitment to improving patient outcomes.
Collaborations
Tomasz Zygmunt has collaborated with esteemed colleagues such as Hans Rommelspacher and Reimar Schlingensiepen. These partnerships have fostered a collaborative environment that enhances the research and development of innovative pharmaceutical solutions.
Conclusion
Tomasz Zygmunt's contributions to the field of pharmaceuticals through his patent and collaborations highlight his dedication to innovation. His work continues to pave the way for advancements in treatments for hearing and vestibular disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile